CVI Investments, Inc. 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:30 pm Sale | 2021-12-31 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 5,333 5.800% | -2,969 (-35.76%) | Filing |
| 2021-05-28 10:33 am Purchase | 2021-05-18 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 8,303 9.900% | 8,303 (New Position) | Filing |